Clinical Trial Update: P3 Study in Acne Comparing Once Daily SB204 and Vehicle [Phase 3]

View source ↗

Summary

Phase 3 trial in acne vulgaris comparing once-daily SB204 to vehicle has completed with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• SB204

Snippet

Sponsor: Novan, Inc. | Conditions: Acne Vulgaris | Phase 3 | Status: COMPLETED | Results posted: 2023-05-06